Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Global - North America
Archived
•
August 7, 2026
•
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
Source: NPR News | https://feeds.npr.org/1001/rss.xml - Read Original
"What you put in is not always what you get out."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Adventure is where you chose to go."
